Journal of Peking University(Health Sciences) ›› 2016, Vol. 48 ›› Issue (3): 442-447. doi: 10.3969/j.issn.1671-167X.2016.03.012

• Article • Previous Articles     Next Articles

Retrospective cohort study for the impact on readmission of patients with ischemic stroke after treatment of aspirin plus clopidogrel or aspirin mono-therapy

YANG Cheng1, ZHANG Yu-qi2, TANG Xun1, GAO Pei1, WEI Chen-lu1, HU Yong-hua1△   

  1. (1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China; 2. Department of Education, Peking University Health Science Center, Beijing 100191, China)
  • Online:2016-06-18 Published:2016-06-18
  • Contact: HU Yong-hua E-mail:yhhu@bjmu.edu.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China (81230066,81573226)

Abstract:

Objective:To see the influence of different antiplatelet therapies on stroke patients’ readmission by performing a deep data-mining into Beijing Healthcare Insuring Database, based on a large sample size. Methods: Aretrospective cohort study, was adopted to extract patients primarily diagnosed as ischemic stroke from healthcare database. The first hospital records were considered as the patient’s baseline in this study, who were divided into MAPT (aspirin) and DAPT (aspirin and clopidogrel) according to the patient’s baseline medications. A follow-up was conducted to see whether the patients would have rehospitalization record because of major result events after medication. The major result events, included: (1) recurrence of ischemic stroke; (2) hemorrhagic transformation of ischemic stroke; (3) myocardial infarction; (4) the digestive hemorrhage. The Kaplan-Meier figure was used to compare the survival situations between these two groups, the log-rank test was used to test the difference of the survival curve, and 1 ∶1 propensity score matching was calculated from the patients’ baseline data. Cox proportional hazards model was used to calculate the hazard ratio (HR).  Results: A total of 27 695 patients From January 2010 to September 2013 were included, 4 047 with DAPT, and 23 648 with MAPT. Because the baseline characteristics of the patients was disequilibrium, so we used 1 ∶1 propensity score matching, after which, the number of the two groups was 4 046 each. Adjusted for the general demographic characteristics such as age, sex, nationality, complication and drug combination, no statistical significance was observed between the survival curves of the two groups (P=0.06). HR value of major result events between the groups was 0.91 (0.82-1.01, P=0.07), which was not statistically significant. The covariate gender HR=1.36 (1.20-1.55, P<0.05), accompanied by diabetes HR= 1.36 (1.20-1.54, P<0.05), dyslipidemia HR=1.13 (1.00-1.27, P=1.13), heart disease HR=1.39 (1.22-1.58, P<0.05) was statistically significant. Drug combination with other antiplatelet agents HR=1.05 (0.95-1.17, P>1.05) did not increase the risk of readmission. Conclusion: There was no difference in prevention of readmission between patients with DAPT and MAPT. Patients with complications should actively treat the complications at the same time as they prevent recurrence after first attack.

Key words: Stroke, Brain ischemia, Aspirin, Clopidogrel, Patient readmission

CLC Number: 

  • R743.3
[1] Huan YU,Ruo-tong YANG,Si-yue WANG,Jun-hui WU,Meng-ying WANG,Xue-ying QIN,Tao WU,Da-fang CHEN,Yi-qun WU,Yong-hua HU. Metformin use and risk of ischemic stroke in patients with type 2 diabetes: A cohort study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 456-464.
[2] Ming-lu ZHANG,Qiu-ping LIU,Chao GONG,Jia-min WANG,Tian-jing ZHOU,Xiao-fei LIU,Peng SHEN,Hong-bo LIN,Xun TANG,Pei GAO. Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 480-487.
[3] Ruo-tong YANG,Meng-ying WANG,Chun-nan LI,Huan YU,Xiao-wen WANG,Jun-hui WU,Si-yue WANG,Jia-ting WANG,Da-fang CHEN,Tao WU,Yong-hua HU. Interaction between ischemic stroke risk loci identified by genome-wide association studies and sleep habits [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 412-420.
[4] Yu-han DENG,Yong JIANG,Zi-yao WANG,Shuang LIU,Yu-xin WANG,Bao-hua LIU. Long short-term memory and Logistic regression for mortality risk prediction of intensive care unit patients with stroke [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 458-467.
[5] WU Jun-hui,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,QIN Xue-ying,WANG Meng-ying,WANG Xiao-wen,WANG Jia-ting,HU Yong-hua. Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 249-254.
[6] REN Guo-yong,WU Xue-mei, ,LI Jie-yu,SUN Wei-ping,HUANG Yi-ning. Susceptibility vessel sign in subacute stroke patients with large vessel occlusion [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1133-1138.
[7] Ya-fei LIU,Lin-lin SONG,Mao-wei XING,Li-xin CAI,Dong-xin WANG. Comparison of pulse pressure variation, stroke volume variation, and plethysmographic variability index in pediatric patients undergoing craniotomy [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 946-951.
[8] LIN Yu,WU Jing-yi,LIN Ke,HU Yong-hua,KONG Gui-lan. Prediction of intensive care unit readmission for critically ill patients based on ensemble learning [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 566-572.
[9] Yue HOU,Xu-tong ZHAO,Zhi-ying XIE,Yun YUAN,Zhao-xia WANG. Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 851-855.
[10] Xun TANG,Du-dan ZHANG,Xiao-fei LIU,Qiu-ping LIU,Yang CAO,Na LI,Shao-ping HUANG,Hui-dong DOU,Pei GAO,Yong-hua HU. Application of the China-PAR stroke risk equations in a rural northern Chinese population [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 444-450.
[11] Ying CHEN,Zhong-ning LIU,Bo LI,Ting JIANG. Preparation of aspirin sustained-release microsphere and its in vitro releasing [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 907-912.
[12] Zi-chang JIA,Huan-ju BIAN,Xuan LI,Jing-yuan LUAN,Chang-ming WANG,Qi-jia LIU,Jin-tao HAN. Application of Neuroform EZ stent in the treatment of severe intracranial arterial stenosis with complex symptomatic [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 835-839.
[13] Zi-chang JIA,Xuan LI,Xiao-gang LI,Xiang-zhu ZENG,Jing-yuan LUAN,Chang-ming WANG,Jin-tao HAN. Mechanical thrombectomy treatment in patients with acute ischemic stroke: a single center study [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 256-259.
[14] SUN Zhuo-nan, MENG Xiu-li, WANG Jun, GUO Xiang-yang, HAN Jin-tao, QI Qiang. Perioperative stroke effectively treated by an acute stroke team including anesthesia department: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1090-1094.
[15] YANG Rui-li, YU Ting-ting, ZHOU Yan-heng. Acetylsalicylic acid treatment enhanced immunomodulatory function of mesenchymal stem cells derived from gingiva [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 872-877.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!